Pancreatic cancer trials in Israel

In Israel 15 Also abroad 1095

15 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Where
Haifa
Age
18 years and over
People
152 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT04858334
Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Ramat Gan, Tel Aviv
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
No phaseTaking people
Pancreatic Cancer Early Detection Consortium
Where
Ramat Gan
Age
18 years to 90 years
People
20,000 worldwide
Run by
Arbor Research Collaborative for Health
See details and how to joinNCT04970056
Phase 1Taking people
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Where
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
325 worldwide
Run by
AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00
Phase 2/3Taking people
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Where
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
982 worldwide
Run by
Pfizer
See details and how to joinNCT06989437 · EU 2025-522093-36-00
Phase 2Taking people
A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
Where
Jerusalem, Ramat Gan
Age
18 years and over
People
168 worldwide
Run by
AbbVie
See details and how to joinNCT07769502 · EU 2025-524801-33-00
Phase 1Taking people
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Where
Haifa, Tel Aviv
Age
18 years and over
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07261631
No phaseTaking people
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Where
Jerusalem
Age
Up to 17 years
People
1,600 worldwide
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT06651580
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Haifa, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
No phaseTaking people
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Where
Jerusalem, Rehovot, Tel HaShomer
Age
18 years and over
People
120 worldwide
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03334708
Phase 1Taking people
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Where
Tel Aviv
Age
18 years to 100 years
People
162 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06562192
Phase 1Taking people
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Where
Jerusalem
Age
18 years and over
People
914 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00
Phase 1Taking people
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Where
Beer Ya'akov, Haifa, Jerusalem, Kefar Sava, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
694 worldwide
Run by
AbbVie
See details and how to joinNCT05005403
No phaseTaking people
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)
Where
Holon, Jerusalem
Age
18 years and over
People
15
Run by
Alpha Tau Medical LTD.
See details and how to joinNCT05657743
Phase 2Taking people
Namodenoson Treatment of Advanced Pancreatic Cancer
Where
Petah Tikva
Age
18 years and over
People
20
Run by
Can-Fite BioPharma
See details and how to joinNCT06387342